Joint Outcome Study

This study has been completed.

Sponsored by:	Centers for Disease Control and Prevention
Information provided by:	Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:	NCT00207597

Purpose

This study examines the progression of joint disease in children with hemophilia assigned to either standard treatment or enhanced therapy.

Condition
Hemophilia A

Genetics Home Reference related topics: hemophilia

MedlinePlus related topics: Hemophilia Joint Disorders

Study Type:	Observational
Study Design:	Natural History, Longitudinal, Convenience Sample, Prospective Study
Official Title:	A Clinical Trial of Primary Prophylaxis Against Joint Disease in Children With Severe Hemophilia

Further study details as provided by Centers for Disease Control and Prevention:

Estimated Enrollment:	64
Study Start Date:	September 1995
Estimated Study Completion Date:	August 2005

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00207597

Sponsors and Collaborators

Centers for Disease Control and Prevention

Investigators

Principal Investigator:

Marilyn J Manco-Johnson, MD

University of Colorado at Denver and Health Sciences Center

More Information

Publications indexed to this study:

Study ID Numbers:	CDC-NCBDDD-1455, U27/CCU812106
Study First Received:	September 13, 2005
Last Updated:	September 13, 2005
ClinicalTrials.gov Identifier:	NCT00207597
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Hemorrhagic Disorders
Genetic Diseases, Inborn
Hematologic Diseases
Blood Coagulation Disorders

Joint Diseases
Hemophilia A
Hemostatic Disorders

Additional relevant MeSH terms:

Blood Coagulation Disorders, Inherited
Coagulation Protein Disorders

ClinicalTrials.gov processed this record on January 16, 2009